Article Text

Download PDFPDF
Linezolid-induced lactic acidosis
  1. Venkat Ramesh1,
  2. Santosh Gattu1,
  3. Maryam Maqsood2 and
  4. Vishnu Rao2
  1. 1Infectious Diseases, Apollo Hospitals, Hyderabad, India
  2. 2Apollo Hospitals, Hyderabad, India
  1. Correspondence to Dr Venkat Ramesh; venkatramesh.ramesh{at}gmail.com

Abstract

Linezolid is a commonly prescribed antibiotic in clinical practice. Although thrombocytopenia and peripheral neuropathy are frequently encountered following prolonged administration of linezolid, lactic acidosis is a rare adverse drug reaction. We present the case of a patient on linezolid for disseminated multidrug-resistant tuberculosis who presented with vomiting, dyspnoea, hypotension and high anion gap metabolic acidosis. The initial presentation mimicked sepsis syndrome. Ketoacidosis and renal dysfunction were ruled out. There was no history of ingestion of toxins/toxic alcohols. Sepsis was unlikely because extensive radiological and microbiological testing could not identify an infection. Given the possibility of linezolid-induced lactic acidosis (LILA), linezolid was discontinued on admission. The patient’s lactic acidosis resolved, and his overall condition improved. A retrospective diagnosis of LILA was thus established. LILA should be considered when patients on linezolid present with lactic acidosis and other causes for the lactic acidosis have been ruled out.

  • infections
  • tuberculosis
  • unwanted effects / adverse reactions
  • adult intensive care
  • resuscitation

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors VRam and SG wrote the initial draft of the manuscript. MM and VRao collected the patient’s clinical data and reviewed the literature. VRam and SG refined and edited the tables. VRam and SG wrote the final draft of the manuscript. MM and VRao made minor corrections concerning syntax and grammar and approved the final manuscript as it is being submitted. VRam, SG, MM and VRao gave final approval of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.